Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (17048)	7/11/2004 1:11:13 PM
From: Bluegreen	Read Replies (1) \| Respond to of 17367

Bob, I say this in all seriousness. Xoma COULD be becoming a situation of last man out. I don't see ANYTHING standing in Xoma's way to restructure AFTER Castello's sell program goes through. Raptiva's sales are pitiful and Xoma's burn rate is HUGE and remember the DEBT owed to Genentech. Remember in a restructure shares of Xoma could become WORTHLESS!!! In my opinion I think Xoma is a GREAT short at these weak levels, Raptiva poor sales, Genentech ALWAYS bashing Raptiva in regards to competition on conference calls, future indications(reminds me of Neuprex with Baxter),Xoma's HUGE burn rate and last but not least HUGE debt to Genentech. Once again in my opinion I think a restructure is a possibility.

To: Robert K. who wrote (17048)	7/11/2004 5:53:52 PM
From: Bluegreen	Read Replies (1) \| Respond to of 17367

They just can't SELL quick enough. After they sell I don't see ANYTHING that stands in the way of a restructuring. This is the management of YOUR company, Bob. I am thinking last man out......last man out. ENJOY.>>>>>>XOMA Executives to Enter Into Rule 10b5-1 Selling Plans BERKELEY, Calif., Jan 12, 2004 (BUSINESS WIRE) -- XOMA Ltd. (Nasdaq: XOMA) today announced that up to three of its executives, including its Chief Executive Officer, may adopt prearranged trading plans in accordance with guidelines specified by Rule 10b5-1 under the Securities Exchange Act of 1934 and the company's policies with respect to insider sales. Rule 10b5-1 allows officers and directors of public companies, at a time when they are not aware of material nonpublic information, to adopt predetermined plans for selling shares. Under these 10b5-1 plans, each executive will be limited to the sale of the number of common shares represented by share options held by the executive that would otherwise expire in January and February of 2005. In total, up to approximately 675,000 common shares may be sold under these plans. These sales may take place from time to time and may be subject to various market conditions. Each executive's plan will be separate and unrelated to the others.<<<<<<<<<